Betapace AF and Sotylize:
Contraindicated in:
Use Cautiously in:
CV: ARRHYTHMIAS, BRADYCARDIA, HF, PULMONARY EDEMA, orthostatic hypotension, peripheral vasoconstriction.
Derm: itching, rash.
EENT: blurred vision, dry eyes, nasal stuffiness.
Endo: hyperglycemia, hypoglycemia.
GI: constipation, diarrhea, nausea.
GU: erectile dysfunction, ↓ libido.
MS: arthralgia, back pain, muscle cramps.
Neuro: fatigue, weakness, anxiety, dizziness, drowsiness, insomnia, memory loss, mental depression, mental status changes, nervousness, nightmares, paresthesia.
Resp: bronchospasm, wheezing.
Misc: drug-induced lupus syndrome.
Drug-Drug:
(Generic available)
Ventricular Arrhythmias
Renal Impairment
Atrial Fibrillation/Atrial Flutter
Renal Impairment
Absorption: Well absorbed following oral administration (bioavailability 90100%).
Distribution: Crosses the placenta; enters breast milk.
Metabolism/Excretion: Elimination is mostly renal.
Half-life: 12 hr (↑ in renal impairment).
NDC Code*